Últimas noticias sobre Harrow (NASDAQ:HROW) Bolsa

Harrow

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

Harrow Health

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AGMH

ANTE

ARBE

ARLO

ATXI

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FINV

GNPX

GRAB

HNRG

HROW

HYPR

KTCC

VRPX

VSTM

Las acciones de Harrow subieron un 23,1% en el premercado. Descubre qué otras compañías están ganando y perdiendo antes de la apertura.

Las acciones de Harrow (HROW) se disparan un 23%; aquí están 20 acciones que se mueven en el premercado

Harrow Inc

Harrow, Inc. - 8.625% senior notes due 2026

Harrow, Inc. - 11.875% Senior Notes due 2027

Cantor Fitzgerald analyst Andres Sheppard upgrades Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) from Neutral to Overweight and maintains the price target from $425 to $425.

Upgrades

Price Target

Analyst Ratings

TSLA

Cantor Fitzgerald Upgrades Tesla to Overweight, Maintains Price Target to $425

Rosenblatt analyst Kevin Cassidy maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and maintains $220 price target.

NVDA

Rosenblatt Maintains Buy on NVIDIA, Maintains $220 Price Target

Zymo Research said it is pleased with the Court's ruling and expects that its antitrust claims will be further vindicated through discovery and trial.

Legal

QGEN

Zymo Research Says Court Denied QIAGEN GmbH's Partial Motion To Dismiss And In The Alternative, To Stay Certain Counterclaims Brought By Zymo

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">B&amp;G Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>)</h3>
<ul>
<li>Dividend Yield: 10.44%</li>
<li>Piper Sandler analyst Michael Lavery maintained a Neutral rating and cut the price target from $8 to $7 on Feb. 26, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Barclays analyst Brandt Montour maintained an Equal-Weight rating and slashed the price target from $8 to $7 on Nov. 7, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: On Feb. 25, B&amp;G Foods posted better-than-expected quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest BGS <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="908" height="808" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19071547/image-161.png" alt="" class="wp-image-831328" style="width:618px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19071547/image-161.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19071547/image-161-300x267.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19071547/image-161-768x683.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 6.99%</li>
<li>B of A Securities analyst Lisa Lewandowski upgraded the stock from Neutral to Buy and raised the price target from $55 to $65 on Dec. 6, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Barclays analyst Gaurav Jain maintained an Underweight rating and increased the price target from $45 to $46 on Nov. 6, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Recent News: On Jan. 30, the company posted upbeat quarterly sales.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">MO news</a> </li>
</ul>
<h3 class="wp-block-heading">Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>Dividend Yield: 4.87%</li>
<li>Goldman Sachs analyst Adam Samuelson maintained a Sell rating and raised the price target from $47 to $52 on July 17, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Stephens &amp; Co. analyst Ben Bienvenu reiterated an Equal-Weight rating with a price target of $65 on April 3, 2024. This analyst has an accuracy rate of 76%.</li>
<li>Recent News: On Feb. 3, Cal-Maine Foods announced acquisition of feed mill operations in North Carolina.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">CALM news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="923" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19071707/image-163.png" alt="" class="wp-image-831332" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19071707/image-163.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19071707/image-163-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19071707/image-163-768x696.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44375233/top-3-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

Dividends

CALM

Wall Street's Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields

Benchmark analyst Cody Acree reiterates NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and maintains $190 price target.

Reiteration

Benchmark Reiterates Buy on NVIDIA, Maintains $190 Price Target

Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WALD#NASDAQ">WALD</a>) with a Outperform and maintains $6 price target.

WALD

Telsey Advisory Group Maintains Outperform on Waldencast, Maintains $6 Price Target

Equinox Gold's (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EQX#AMEX">EQX</a>) <a target="_blank" href="https://www.benzinga.com/news/legal/25/02/43938698/equinox-gold-buys-calibre-mining-for-1-8-billion-creating-canadas-second-largest-gold-producer" rel="noreferrer noopener">$1.8 billion acquisition</a> of Calibre Mining (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXBMF#OTC">CXBMF</a>) has hit a hurdle. A top shareholder in both companies publicly opposed the plan, citing synergy concerns.
"We are not supportive of this transaction. We don't see any synergies between any of the companies' operations," Imaru Casanova, a portfolio manager at Van Eck, said <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-03-18/top-calibre-investor-opposes-equinox-s-1-8-billion-takeover-bid" rel="noreferrer noopener">per</a> Bloomberg's report on Tuesday.
"Both operate in the Americas, but in vastly different locations," she clarified, arguing that the deal dilutes Calibre's quality and potential, particularly as the company advances its flagship Valentine project in Canada.
According to Bloomberg, Van Eck is the largest Calibre shareholder, holding an 8.52% stake, and the second-largest Equinox shareholder, with an 8.86%.
Equinox announced the all-stock acquisition of Calibre last month as part of its strategy to consolidate gold assets and boost annual production. Equinox operates across Canada, Mexico, Brazil, and the United States, while Calibre's assets are primarily located in the United States and Nicaragua, Bloomberg writes.
Under the proposed structure, Calibre shareholders would receive shares of Equinox instead of cash at a 22% premium. The merger aims to create a mid-tier gold producer with a combined annual output of approximately 1.2 million ounces, placing it among the top 15 global producers.
The deal-making activity is unsurprising given the record-high gold prices, which have encouraged miners to expand. Gold broke the <a target="_blank" href="https://www.benzinga.com/25/03/44325928/gold-smashes-through-3000-mark-as-markets-brace-for-turbulence-and-fed-signals" rel="noreferrer noopener">milestone price of $3,000</a> per ounce last week, driven by central bank purchases and investor demand for safe-haven assets.
Jeffrey Gundlach, CEO of DoubleLine, recently predicted that gold could reach $4,000 per ounce, citing the sharp increase in central bank buying and ongoing geopolitical risks. Meanwhile, analysts at Macquarie have raised their price target to $3,500 per ounce by the third quarter of 2025.
With gold outperforming in 2024, Equinox reported a record year. It produced 621,893 ounces of gold and generated $1.5 billion in revenue, with an operating cash flow of $430 million. Looking ahead to 2025, Equinox expects to produce between 635,000 and 750,000 ounces, with an all-in-sustaining cost (AISC) between $1,455 and $1,550 per ounce.
Thus, even using the upper AISC estimate and assuming an average realized price of $3,000 per ounce, Equinox would generate around $1.1 billion in gross profit, maintaining last year's production level, making a good acquisition a lucrative proposal.
Still, given the lack of geographical proximity to unlock the synergies, Van Eck's opposition might shape investor sentiment, as approval requires support from two-thirds of both companies' shareholders.
Price Watch: VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) is up 32.81% year-to-date.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/03/44335436/gold-etfs-shine-as-spot-price-tops-3000-during-safe-haven-demand" target="_blank" rel="noreferrer noopener">Gold ETFs Shine As Spot Price Tops $3,000 During Safe-Haven Demand</a></li>
</ul>
Image via Shutterstock

Equities

Guidance

Commodities

CXBMF

Market Vectors ETF Trust Market Vectors Gold Miners

GLDM

OUNZ

SGOL

Calibre Mining's Largest Shareholder Opposes Equinox's $1.8 Billion Acquisition

MCHP

Microchip Launches AV SD Family Of MCUs With Built-in Safety Features, Meeting ASIL C And SIL 2 Standards For Automotive Applications

In yet another attack against Elon Musk's EV giant, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) vehicles have been the target of arson attacks in Las Vegas and Kansas City.
What Happened: Early Tuesday, a suspect clad in black reportedly launched an attack on a Tesla collision center in Las Vegas using Molotov cocktails and firearms, according to <a href="https://www.reviewjournal.com/crime/several-vehicle-set-on-fire-at-tesla-in-las-vegas-police-say-3322726/">a</a> report by the Las Vegas Review-Journal.
The suspect also defaced the facility by painting &#8220;resist&#8221; on its doors. Deputy Fire Chief Jennifer Wyatt noted that firefighters successfully extinguished two Tesla vehicles before their batteries caught fire.
The FBI's joint terrorism task force is now handling the investigation as an arson case, according to the report.
See Also: <a href="https://www.benzinga.com/25/03/44392619/elon-musks-tesla-secures-first-approval-towards-rolling-out-robotaxi-in-california">Elon Musk&#8217;s Tesla Secures First Approval Towards Rolling Out Robotaxi In California</a>
FBI Special Agent Spencer Evans has cautioned potential perpetrators against such actions. Musk, Tesla&#8217;s CEO, described the incidents as &#8220;terrorism&#8221; on X, asserting that Tesla has done nothing to deserve such attacks.
U.S. Attorney General Pamela Bondi echoed this sentiment, labeling the incidents as &#8220;domestic terrorism&#8221; and pledging thorough investigations.
In Kansas City, smoke was seen emanating from a Tesla Cybertruck, which led to a fire that spread to another vehicle. Police Captain Jacob Becchina mentioned that the fire is being investigated for possible arson.
The suspect in Las Vegas remains at large, with no updates from the Las Vegas Metropolitan Police since the press conference.
Why It Matters: This is not the first time Tesla has faced such challenges. Earlier this month, a Tesla Supercharger station in Littleton, Massachusetts was<a href="https://www.benzinga.com/25/03/44100938/tesla-supercharger-in-littleton-massachusetts-set-on-fire-ev-company-says-no-customers-were-charging"> set</a> on fire, prompting a reward offer for information leading to the arrest of the perpetrators.
Musk recently condemned attacks on Tesla vehicles, emphasizing that <a href="https://www.benzinga.com/25/03/44135841/elon-musk-slams-attacks-on-tesla-vehicles-after-incident-in-brookline-vandalism-is-not-free-speech">vandalism is not free speech</a>. Furthermore, a <a href="https://www.benzinga.com/news/25/03/44348055/anti-musk-protester-vandalizes-tesla-cybertruck-with-swastika-shocking-jewish-owner">Tesla Cybertruck was vandalized</a> with a swastika in New York City, shocking its Jewish owner.
These attacks come amid sharp criticism of Musk over his role with President Donald Trump administration's Department of Government Efficiency (DOGE).
Check out more of Benzinga&#8217;s Future Of Mobility coverage by <a href="https://www.benzinga.com/topic/mobility">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44354592/warren-buffett-backed-byd-eyes-germany-for-third-european-plant-amid-tariff-concerns-report">Warren Buffett-Backed BYD Eyes Germany For Third European Plant Amid Tariff Concerns: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

Media

Elon Musk's Tesla Targeted With Arson Attacks In Las Vegas, Kansas City: Report

CRDO

Credo Technology Group Announces Strategic Partnership With WPG Americas

TRNR

Interactive Strength Issues Shareholder Update; Reiterates $50M+ Pro Forma Guidance, Additional $15M+ Revenue Deal That Is Expected To Raise Guidance

WIIM

HealthEquity shares are trading lower after the company reported worse-than-expected Q4 Adj. EPS results.

Needham analyst John Todaro maintains Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) with a Buy and lowers the price target from $18 to $15.

BTDR

Needham Maintains Buy on Bitdeer Technologies, Lowers Price Target to $15

ATER

Aterian shares are trading higher after the company reported better-than-expected Q4 financial results.

Stifel analyst Thomas Stephan maintains RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) with a Hold and lowers the price target from $33 to $28.

RXST

Stifel Maintains Hold on RxSight, Lowers Price Target to $28

General Mills shares are trading lower after the company reported mixed Q3 results and said it expects macroeconomic uncertainty to continue impacting consumers in Q4.

VEEV

Indero Launches Its 40Th RTSM Study On Veeva RTSM

BNTC

Benitec Biopharma Reports Positive Interim Clinical Results For Three Subjects Treated With BB-301 In Phase 1b/2a Study

CREV

Carbon Revolution Appoints Donnie Hampton As Acting CEO

DTIL

Precision BioSciences Presents Preclinical Data For Its PBGENE-DMD Development Program For Treatment Of Duchenne Muscular Dystrophy

Press Releases

Harrow Announces Participation in Upcoming Investor Conferences

Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery

Harrow's ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.

OSRX, Inc. Responds to Jury Verdict in Trademark Infringement Case

Harrow Appoints Amir H. Shojaei as Chief Scientific Officer

Harrow Partners with Cencora to Launch "Harrow Cares" Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025

Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®

Harrow Launches VEVYE® Access for All

Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance

Comments

Harrow

Noticias

Últimas noticias sobre Harrow (NASDAQ:HROW) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL